BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28317292)

  • 1. Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy.
    Gadalla SM; Hilbert JE; Martens WB; Givens S; Moxley RT; Greene MH
    Eur J Neurol; 2017 May; 24(5):713-718. PubMed ID: 28317292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlates of tumor development in patients with myotonic dystrophy.
    Das M; Moxley RT; Hilbert JE; Martens WB; Letren L; Greene MH; Gadalla SM
    J Neurol; 2012 Oct; 259(10):2161-6. PubMed ID: 22619053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign and malignant tumors in the UK myotonic dystrophy patient registry.
    Alsaggaf R; Wang Y; Marini-Bettolo C; Wood L; Nikolenko N; Lochmüller H; Greene MH; Gadalla SM
    Muscle Nerve; 2018 Feb; 57(2):316-320. PubMed ID: 28662292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy).
    Naldi L; Altieri A; Imberti GL; Gallus S; Bosetti C; La Vecchia C;
    Cancer Causes Control; 2005 Oct; 16(8):893-9. PubMed ID: 16132799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain tumors in patients with myotonic dystrophy: a population-based study.
    Gadalla SM; Pfeiffer RM; Kristinsson SY; Björkholm M; Landgren O; Greene MH
    Eur J Neurol; 2016 Mar; 23(3):542-7. PubMed ID: 26508558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.
    Wang Y; Pfeiffer RM; Alsaggaf R; Meeraus W; Gage JC; Anderson LA; Bremer RC; Nikolenko N; Lochmuller H; Greene MH; Gadalla SM
    Int J Cancer; 2018 Mar; 142(6):1174-1181. PubMed ID: 29114849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study.
    Wolf P; Quehenberger F; Müllegger R; Stranz B; Kerl H
    Melanoma Res; 1998 Aug; 8(4):370-8. PubMed ID: 9764814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate.
    Newton-Bishop JA; Chang YM; Elliott F; Chan M; Leake S; Karpavicius B; Haynes S; Fitzgibbon E; Kukalizch K; Randerson-Moor J; Elder DE; Bishop DT; Barrett JH
    Eur J Cancer; 2011 Mar; 47(5):732-41. PubMed ID: 21084183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Similarities to melanoma: the Vancouver Mole Study.
    Gallagher RP; McLean DI; Yang CP; Coldman AJ; Silver HK; Spinelli JJ; Beagrie M
    Arch Dermatol; 1990 Jun; 126(6):770-6. PubMed ID: 2346321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin.
    Khalesi M; Whiteman DC; Tran B; Kimlin MG; Olsen CM; Neale RE
    Cancer Epidemiol; 2013 Oct; 37(5):534-43. PubMed ID: 23849507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case-control study in Belgium, France and Germany. The EORTC Malignant Melanoma Cooperative Group.
    Autier P; Doré JF; Lejeune F; Koelmel KF; Geffeler O; Hille P; Cesarini JP; Liénard D; Liabeuf A; Joarlette M
    Melanoma Res; 1994 Apr; 4(2):79-85. PubMed ID: 8069100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis.
    Emparanza JI; López de Munain A; Greene MH; Matheu A; Fernández-Torrón R; Gadalla SM
    Muscle Nerve; 2018 Oct; 58(4):517-522. PubMed ID: 30028904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).
    Hilbert JE; Kissel JT; Luebbe EA; Martens WB; McDermott MP; Sanders DB; Tawil R; Thornton CA; Moxley RT;
    Contemp Clin Trials; 2012 Mar; 33(2):302-11. PubMed ID: 22155025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival patterns and cancer determinants in families with myotonic dystrophy type 1.
    Best AF; Hilbert JE; Wood L; Martens WB; Nikolenko N; Marini-Bettolo C; Lochmüller H; Rosenberg PS; Moxley RT; Greene MH; Gadalla SM
    Eur J Neurol; 2019 Jan; 26(1):58-65. PubMed ID: 30051542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of tumor in DM1 is not related to exposure to common lifestyle risk factors.
    Bianchi ML; Leoncini E; Masciullo M; Modoni A; Gadalla SM; Massa R; Rastelli E; Terracciano C; Antonini G; Bucci E; Petrucci A; Costanzi S; Santoro M; Boccia S; Silvestri G
    J Neurol; 2016 Mar; 263(3):492-8. PubMed ID: 26739382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-control study of malignant melanoma in Washington State. I. Constitutional factors and sun exposure.
    White E; Kirkpatrick CS; Lee JA
    Am J Epidemiol; 1994 May; 139(9):857-68. PubMed ID: 8166136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sun protection behaviors of the U.S. white population.
    Hall HI; May DS; Lew RA; Koh HK; Nadel M
    Prev Med; 1997; 26(4):401-7. PubMed ID: 9245656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries.
    Higgs C; Hilbert JE; Wood L; Martens WB; Marini-Bettolo C; Nikolenko N; Alsaggaf R; Lochmüller H; Moxley RT; Greene MH; Wang Y; Gadalla SM
    Front Neurol; 2019; 10():1071. PubMed ID: 31681146
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women.
    Veierød MB; Weiderpass E; Thörn M; Hansson J; Lund E; Armstrong B; Adami HO
    J Natl Cancer Inst; 2003 Oct; 95(20):1530-8. PubMed ID: 14559875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.